American Society of Hirudotherapy

Successful local use of heparin calcium for congested fingertip replants

Observational published in Arch Plast Surg (2020)

Last Updated: November 1, 2026ASH Editorial · based on the books
Research article — evidence review: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Article reference: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.
Evidence: Research reportClinical LiteratureDrug DevelopmentKadota H et al. · Archives of plastic surgery, 2020

Abstract

BACKGROUND: Conventional methods of external bleeding for congested fingertip replants exhibit notable problems, including uncontrollable bleeding and unpredictable survival of the replant. We have added a local injection of heparin calcium to the routine use of systemic heparinization for inducing external bleeding. We retrospectively examined patients who underwent external bleeding using our method. METHODS: Local subcutaneous injections of heparin calcium were made in 15 congested replants in addition to systemic heparinization. Each injection ranged from 500 to 5,000 U. The average duration of the injections was 4.1 days. Surgical outcomes were analyzed and compared with a control group of patients who underwent external bleeding without heparin calcium. RESULTS: The overall survival rate was 93.3%, which was higher than that of the control group (83.3%), but the difference was not statistically significant (P=0.569). The survival rate for subzones I and II by the Ishikawa subzone classification was 100%, whereas it was 87.5% in subzones III and IV. No statistically significant difference was observed. The rate of partial necrosis was 0% in subzones I and II, whereas it was significantly higher (66.7%) in subzones III and IV (P=0.015). The mean total blood loss via external bleeding was 588 g in 10 fingers. No patients required blood transfusion. CONCLUSIONS: Congestion of a replanted fingertip can be successfully managed without blood transfusion by our method. Although complete relief from congestion in replants in subzones I and II is achievable, there is a higher risk of partial necrosis in subzones III and IV.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Summary

In 15 congested fingertip replants, local heparin calcium injections added to systemic heparinization achieved 93.3% survival without transfusions; partial necrosis was significantly more common in subzones III and IV (66.7%).

Context

This retrospective study examined local subcutaneous heparin calcium injections (500-5,000 U per injection, mean 4.1 days) added to systemic heparinization for inducing external bleeding in 15 congested fingertip replants. The survival rate was 93.3% (vs 83.3% control, NS), with 100% survival in Ishikawa subzones I-II but significantly higher partial necrosis (66.7%) in subzones III-IV; no transfusions were required. The study addresses an alternative to leech therapy for managing venous congestion in digital replantation. It does not involve leeches.

Citation

Reference (Vancouver style)

Kadota H, Imaizumi A, Ishida K, Sashida Y. Successful local use of heparin calcium for congested fingertip replants. Arch Plast Surg. 2020;47(1):54-61. doi:10.5999/aps.2019.00815. PMID: 31964124

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

Added to ASH library: May 27, 2026 · Site last updated: November 1, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.